摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1R,cis)-3-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-1-cyclopentane-1-methanol | 267668-72-4

中文名称
——
中文别名
——
英文名称
(1R,cis)-3-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-1-cyclopentane-1-methanol
英文别名
(1R,3S)-3-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopentanemethanol;[(1R,3S)-3-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopentyl]methanol
(1R,cis)-3-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-1-cyclopentane-1-methanol化学式
CAS
267668-72-4
化学式
C14H20N6O
mdl
——
分子量
288.352
InChiKey
TYPRESGPNUCUCA-SCZZXKLOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    21
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.64
  • 拓扑面积:
    102
  • 氢给体数:
    3
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (1R,cis)-3-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-1-cyclopentane-1-methanol吡啶亚磷酸二苯酯氯磷酸二苯酯 作用下, 以 吡啶二氯甲烷 为溶剂, 反应 0.74h, 生成 triethylammonium (1S,cis)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methyl [N-(4-methylthiazol-2-yl)]phosphoramidate
    参考文献:
    名称:
    Aryl H-Phosphonates 18. Synthesis, properties, and biological activity of 2′,3′-dideoxynucleoside (N-heteroaryl)phosphoramidates of increased lipophilicity
    摘要:
    Recently, AZT (N-pyridyl)phosphoramidates were reported as a new type of potential anti-HIV therapeutics. In continuation of that work, here we present new (N-heteroaryl)phosphoramidate derivatives of antiviral 2',3'-dideoxynucleosides containing other types of N-heteroaryl moieties, particularly those with higher lipophilicity. The present studies comprise mechanistic investigations using P-31 NMR correlation analysis, which permitted improvements in the synthetic procedures. The obtained compounds were tested in biological systems to establish their cytotoxicity and anti-HIV activity. The results were analyzed with respect to possible correlations between biological and physico-chemical properties of the phosphoramidates studied, to get some,insight into their antiviral mode of action. (C) 2015 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2015.06.004
  • 作为产物:
    描述:
    阿巴卡韦 在 palladium on activated charcoal 氢气 作用下, 以 乙醇 为溶剂, 反应 1.5h, 以98%的产率得到(1R,cis)-3-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-1-cyclopentane-1-methanol
    参考文献:
    名称:
    An Efficient, Scalable Synthesis of the HIV Reverse Transcriptase Inhibitor Ziagen® (1592U89)
    摘要:
    Ziagen(R), (IS, cis)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol, was synthesized from (IS,4R)-azabicyclo[2.2.1]hept-5-en-3-one by efficient processes which bypass problematic steps in earlier routes. 2-Amino-4,6-dichloro-5-formamidopyrimidine is a key intermediate which makes possible an efficient construction of the purine from a chiral cyclopentenyl precursor.
    DOI:
    10.1080/15257770008033011
点击查看最新优质反应信息

文献信息

  • [EN] STABILIZATION OF MHC COMPLEXES<br/>[FR] STABILISATION DE COMPLEXES CMH
    申请人:UNIV CALIFORNIA
    公开号:WO2021133742A1
    公开(公告)日:2021-07-01
    Provided, inter alia, are methods and compositions for treating cancer.
    提供了治疗癌症的方法和组合物,包括但不限于。
  • Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients
    申请人:SIPOS TIBOR
    公开号:US20100021505A1
    公开(公告)日:2010-01-28
    Method of preventing or reducing diarrhea and/or steatorrhea in HIV-positive patients being treated with High Activity Antiretroviral drugs containing protease inhibitors, nucleoside reverse transcriptase inhibitors or non-nucleoside reverse transcriptase inhibitors. The method includes the steps of: administering to the HIV-positive patient a High Activity Antiretroviral drug containing a protease inhibitor, a nucleoside reverse transcriptase inhibitor or a non-nucleoside reverse transcriptase inhibitor; and co-administering with the HAART drug a gastric acid-resistant polymer-coated and buffered digestive enzyme composition containing pancreatic proteases, lipases, co-lipases, nucleases, amylases and other bio-active substances produced by the pancreatic gland.
    预防或减少HIV阳性患者在接受含有蛋白酶抑制剂、核苷酸反转录酶抑制剂或非核苷酸反转录酶抑制剂的高活性抗逆转录病毒药物治疗时出现腹泻和/或脂肪泻的方法。该方法包括以下步骤:给HIV阳性患者口服含有蛋白酶抑制剂、核苷酸反转录酶抑制剂或非核苷酸反转录酶抑制剂的高活性抗逆转录病毒药物;同时与HAART药物联合给予一种胃酸耐受性聚合物包膜和缓冲的消化酶组合物,其中包含胰蛋白酶脂肪酶、胆脂酶、核酸酶淀粉酶和胰腺分泌的其他生物活性物质。
查看更多

同类化合物

马来酸恩替卡韦 顺式5-氟-1-[2-(羟甲基)-1,3-氧硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮-13C,15N2 顺式5-氟-1-[2-(羟甲基)-1,3-氧硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮 顺-5-氟-1-[2-[[[[(((1,1-二甲基乙基)二甲基甲硅烷基]氧基]甲基]-1,3-氧杂硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮-13C,15N2 顺-5-氟-1-[2-[[[[(((1,1-二甲基乙基)二甲基甲硅烷基]氧基]甲基]-1,3-氧杂硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮 阿巴卡韦羧酸盐 阿巴卡韦相关物质D 阿巴卡韦杂质F 阿巴卡韦杂质 阿巴卡韦中间体A5 阿巴卡韦5’-磷酸酯 阿巴卡韦,拉米夫定混合物 阿巴卡韦 阿巴卡韦 铁(2+)乙二酸酯-丁烷-1-胺(1:1:2) 贝伐西尼 苯甲酸,3-(2-氨基-2-氰基乙酰基)-,乙基酯 芒霉素 艾夫他滨 腺苷基(3'-5')胞苷基(3'-5')胞苷游离酸 腺苷-3',5'-环硫代磷酸酯 腺苷-2',3'-环单硫代磷酸酯,盐内/RP-同质异能素钠 脱氧假尿苷 胸苷酰-(5'-3')-胸苷酰-(5'-3')-胸苷酰-(5'-3')-5'-胸苷酸 胰腺癌RX-3117 硫酸阿巴卡韦 甲基磷羧酸氢[(2S,5R)-5-(4-氨基-2-羰基嘧啶-1(2H)-基)-2,5-二氢呋喃-2-基]甲酯 瓶型酵母D 瓶型酵母A 环戊烯基尿嘧啶 水杨酸拉米呋啶 氟达拉滨EP杂质H 曲沙他滨 拉米夫定相关化合物(Α-TROXACITABINE) 拉米夫定杂质Ⅲ1-[(2R,5S)-2-羟甲基-1,3-氧硫杂环戊-5-基]-嘧啶-2,4(1H,3H)-酮 拉米夫定杂质27 拉米夫定杂质1 拉米夫定单磷酸铵盐 拉米夫定二磷酸酯铵盐 拉米夫定S-氧化物(异构体混合物) 拉米夫定 拉米夫定 拉夫米定EP杂质J 拉夫米定EP杂质H 扎西他宾 恩替卡韦相关物质A 恩替卡韦杂质SSS 恩替卡韦一水合物 恩曲他滨杂质16 恩曲他滨S-氧化物